Bisker-Leib Vered's Form 4 filing
Compass Therapeutics, Inc. (CMPX) · filed Nov 22, 2022
- Accession no.
- 0001171843-22-007635
- Filed
- Nov 22, 2022
- Trade date
- Nov 18-21, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $97.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bisker-Leib VeredCIK 0001814093 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Common Stock | SSaleDisposed | −6,226 | $4.40 | −$27,394.4 | 1,107,175 | Direct | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −16,035 | $4.34 | −$69,591.9 | 1,084,914 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.